Treating young individuals at clinical high risk for psychosis

Early Intervention in Psychiatry

Volumn 6, Issue 1, 2012, Pages 60-68

  Marshall, Catherine ^a   Addington, Jean ^a,c,d   Epstein, Irvin ^c   Liu, Lu ^a   Deighton, Stephanie ^b   Zipursky, Robert B ^e  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Prodrome; Psychosis; Treatment outcome

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGREEABLENESS; ALCOHOL ABUSE; ANXIETY; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE THERAPY; CONSCIENTIOUSNESS; CONTROLLED STUDY; DEPRESSION; DRUG ABUSE; EXTRAVERSION; FEMALE; HEALTH BELIEF; HIGH RISK POPULATION; HUMAN; MALE; NEGATIVE SYNDROME; NEUROSIS; PERSONALITY; PERSONALITY DISORDER; PERSONALITY TEST; POSITIVE SYNDROME; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOSIS; PSYCHOSOCIAL REHABILITATION; PSYCHOTHERAPY; SCORING SYSTEM; SOCIAL STATUS; STRUCTURED INTERVIEW; SUBSTANCE ABUSE; SUPPORTIVE THERAPY; TREATMENT DURATION;

ADOLESCENT; ADULT; COGNITION; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PERSONALITY ASSESSMENT; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; PSYCHOTROPIC DRUGS;

EID: 84856318317     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/j.1751-7893.2011.00299.x     Document Type: Article

References (32)

1. McGlashan T, Walsh BC, Woods SW. The Psychosis Risk Syndrome: Handbook for Diagnosis and Follow-up. New York: Oxford University Press, 2010.
2. Yung AR, McGorry PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry 1996; 30: 587-99.
3. McGorry PD, Nelson B, Amminger GP etal. Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry 2009; 70: 1206-12.
4. Preti A, Cella M. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophr Res 2010; 123: 30-6.
5. Woods SW, Addington J, Cadenhead KS etal. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull 2009; 35: 894-908.
6. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull 2003; 29: 633-51.
7. Addington J, Penn D, Woods SW, Addington D, Perkins DO. Social functioning in individuals at clinical high risk for psychosis. Schizophr Res 2008; 99: 119-24.
8. Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B. Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophr Res 2004; 68: 37-48.
9. Yung A, Phillips L, McGorry PD. Establishing a clinical high risk service for ultra high risk individuals. In: Yung A, Phillips L, McGorry PD, eds. Treating Schizophrenia in the Prodromal Phase. New York: Taylor & Francis, 2004; 35-50.
10. Schultze-Lutter F, Ruhrmann S, Klosterkotter J. Early detection of psychosis - Establishing a service for persons at risk. Eur Psychiatry 2009; 24: 1-10.
11. Broome MR, Woolley JB, Johns LC etal. Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. Eur Psychiatry 2005; 20: 372-8.
12. Carr V, Halpin S, Lau N, O'Brien S, Beckmann J, Lewin T. A risk factor screening and assessment protocol for schizophrenia and related psychosis. Aust N Z J Psychiatry 2000; 34: S170-80.
13. Addington J, Cornblatt B, Cadenhead K etal. At clinical high risk for psychosis: outcome for non-converters. Am J Psychiatry 2011; 168: 800-5.
14. Simon AE, Umbricht D. High remission rates from an initial ultra-high risk state for psychosis. Schizophr Res 2010; 116: 168-72.
15. Ruhrmann S, Bechdolf A, Kuhn KU etal. Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. Br J Psychiatry 2007; 191 (Suppl. 51): s88-95.
16. Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res 2010; 125: 54-61.
17. Addington J, Epstein I, Reynolds A etal. Early detection of psychosis: finding those at clinical high risk. Early Interv Psychiatry 2008; 2: 147-53.
18. First M, Spitzer RL, Gibbon M, Williams B, Williams JBW. Structured clinical interview for DSM-IV axis I disorders, patient edition. New York: Biometrics Research Department, New York State Psychiatric Institute, 1995.
19. Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary depression scale. Br J Psychiatry 1993; 163: 39-44.
20. Olivares J, Garcia-Lopez LJ, Hidalgo MD. The Social Phobia Scale and the Social Interaction Anxiety Scale: factor structure and reliability in a Spanish speaking population. J Psychoeducational Assess 2001; 19: 69-80.
21. Drake RE, Mueser K, McHugo G. Clinical rating scales. In: Sederer L, Dickey B, eds. Outcomes Assessment in Clinical Practice. Baltimore, MD: Williams and Wilkins, 1996; 113-6.
22. Hall RCW. Global assessment functioning: a modified scale. Psychosomatics 1995; 36: 267-75.
23. Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The social functioning scale: the development and validation of a new scale adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry 1990; 157: 853-9.
24. Goldberg DP, Hillier VF. A scaled version of the general health questionnaire. Psychol Med 1979; 9: 139-45.
25. Piedmont RL. The Revised NEO Personality Inventory: Clinical and Research Applications. New York: Plenum Press, 1998.
26. Cartwright-Hatton S, Wells A. Beliefs about worry and intrusions: the Meta-Cognitions Questionnaire and its correlates. J Anxiety Disord 1997; 11: 279-96.
27. Morrison AP, French P, Wells A. Metacognitive beliefs across the continuum of psychosis: comparisons between patients with psychotic disorders, patients at ultra-high risk and non-patients. Behav Res Ther 2007; 45: 2241-6.
28. Morrison AP, French P, Walford L etal. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 2004; 185: 291-7.
29. Gurrera RJ, Nestor PG, O'Donnell BF. Personality traits in schizophrenia: comparison with a community sample. J Nerv Ment Dis 2000; 188: 31-5.
30. Lysaker PH, Taylor AC. Personality dimensions in schizophrenia: associations with symptoms and coping concurrently and 12months later. Psychopathology 2007; 40: 338-44.
31. Velthorst E, Nieman DH, Klaassen RM etal. Three-year course of clinical symptomatology in young people at ultra high risk for transition to psychosis. Acta Psychiatr Scand 2011; 123: 36-42.
32. Yung AR. Antipsychotic treatment of UHR ('prodromal') individuals. Early Interv Psychiatry 2010; 4: 197-9.